From 4C 24-7-2020 (like two weeks ago..) "With prudent cash management actions in place and the deferral of the initiation of the strategic growth initiatives which were announced in March, AdAlta is confident that existing cash resources are sufficient to achieve its forecast AD-214 milestones (top line safety results from the healthy volunteer part of the Phase I program and development of the radio-labelled PET imaging agent version of AD-214, currently anticipated by early 2021)."
Hidden meaning... "in two weeks we will announce a 50% dilution of the shares to reward those who have held our preclinical company for the last several years. Now that we have reached the clinic, we don't want the share price to go up too much..."
1AD Price at posting:
11.3¢ Sentiment: None Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)